BioCryst Pharmaceuticals Inc (BCRX)
8.43
+0.42
(+5.24%)
USD |
NASDAQ |
Nov 01, 16:00
8.50
+0.07
(+0.83%)
After-Hours: 20:00
BioCryst Pharmaceuticals Max Drawdown (5Y): 90.24% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 90.24% |
| September 30, 2024 | 90.24% |
| August 31, 2024 | 90.33% |
| July 31, 2024 | 90.33% |
| June 30, 2024 | 90.33% |
| May 31, 2024 | 90.33% |
| April 30, 2024 | 90.33% |
| March 31, 2024 | 90.33% |
| February 29, 2024 | 90.33% |
| January 31, 2024 | 90.33% |
| December 31, 2023 | 90.33% |
| November 30, 2023 | 90.33% |
| October 31, 2023 | 90.33% |
| September 30, 2023 | 90.33% |
| August 31, 2023 | 90.33% |
| July 31, 2023 | 90.33% |
| June 30, 2023 | 90.33% |
| May 31, 2023 | 90.33% |
| April 30, 2023 | 90.33% |
| March 31, 2023 | 90.33% |
| February 28, 2023 | 90.33% |
| January 31, 2023 | 90.33% |
| December 31, 2022 | 90.33% |
| November 30, 2022 | 90.33% |
| October 31, 2022 | 90.33% |
| Date | Value |
|---|---|
| September 30, 2022 | 90.33% |
| August 31, 2022 | 90.33% |
| July 31, 2022 | 90.33% |
| June 30, 2022 | 90.33% |
| May 31, 2022 | 90.33% |
| April 30, 2022 | 90.33% |
| March 31, 2022 | 90.33% |
| February 28, 2022 | 90.33% |
| January 31, 2022 | 90.33% |
| December 31, 2021 | 90.33% |
| November 30, 2021 | 90.33% |
| October 31, 2021 | 90.33% |
| September 30, 2021 | 90.33% |
| August 31, 2021 | 90.33% |
| July 31, 2021 | 90.33% |
| June 30, 2021 | 90.33% |
| May 31, 2021 | 90.33% |
| April 30, 2021 | 90.33% |
| March 31, 2021 | 90.33% |
| February 28, 2021 | 90.33% |
| January 31, 2021 | 90.33% |
| December 31, 2020 | 90.33% |
| November 30, 2020 | 90.33% |
| October 31, 2020 | 90.33% |
| September 30, 2020 | 90.33% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
90.24%
Minimum
Sep 2024
90.33%
Maximum
Nov 2019
90.33%
Average
90.33%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| Novavax Inc | 98.82% |
| AIM ImmunoTech Inc | 99.61% |
| Perspective Therapeutics Inc | 91.70% |
| Protalix BioTherapeutics Inc | 94.35% |
| Armata Pharmaceuticals Inc | 99.87% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 5.231 |
| Beta (5Y) | 1.890 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 80.33% |
| Historical Sharpe Ratio (5Y) | 0.3687 |
| Historical Sortino (5Y) | 0.9372 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 22.46% |